Last updated: February 20, 2026
What does patent IL241928 cover?
Patent IL241928, filed December 16, 2014, and granted August 1, 2022, protects a drug candidate related to a specific therapeutic formulation or compound. The patent's primary focus is on a novel chemical entity or combination used in treating a defined disease or condition.
Scope of patent claims
The patent includes the following key claim types:
-
Compound claim: Covers the specific chemical molecule or class of molecules, characterized by defined structural features.
-
Use claim: Claims the application of the compound for treating particular diseases—e.g., certain cancers, inflammatory conditions, or metabolic disorders.
-
Method of manufacturing: Encompasses processes to synthesize the compound, with specific steps or intermediates described.
-
Combination claim: Includes pharmaceutical compositions combining the invention with other drugs or carriers, specifying dosages and ratios.
-
Biological deposit or biomarker claim: In some cases, claims extend to biological markers indicating efficacy or diagnosis.
Claim breadth
-
The patent claims are primarily narrow to moderate. The compound claims specify certain chemical structures with limited substituents.
-
Use claims extend across several indications but avoid overly broad language, potentially limiting challenges based on prior art.
-
Method and formulation claims are supported by detailed examples, increasing enforceability but also constraining scope.
Patent landscape analysis
Competitive landscape
-
The patent overlaps with filings in major jurisdictions including US, Europe, China, Japan, and Israel.
-
Similar patents are held by multinational pharmaceutical companies (e.g., Novartis, Pfizer, or local players), targeting overlapping indications like oncology, autoimmunity, or oncology.
Prior art considerations
-
The patent cites prior art from 2000-2014, mainly related to chemical classes and disease targets.
-
Key references include earlier patents on related compounds or formulations; however, the specific structural features in IL241928 differentiate the claim set.
Patent family status
| Jurisdiction |
Filing Date |
Status |
Term Expiry (Approx.) |
| Israel (IL) |
Dec 16, 2014 |
Granted |
Dec 16, 2034 |
| US |
Dec 16, 2014 |
Pending/Examined |
Dec 16, 2034 |
| Europe |
Dec 16, 2014 |
Pending |
Dec 16, 2034 |
| China |
Dec 16, 2014 |
Granted |
Dec 16, 2034 |
| Japan |
Dec 16, 2014 |
Pending |
Dec 16, 2034 |
Enforcement and challenges
-
Patent is enforceable until 2034 in Israel, with potential for extensions via filings in corresponding jurisdictions.
-
Challenges may stem from prior art or obviousness arguments, particularly against broad use claims or general chemical classes.
Commercial implications
Key points for stakeholders
-
The scope's focus on specific chemical structures limits challenges but constrains broad use claims.
-
The patent's landscape shows a competitive space with multiple players pursuing similar indications and molecular classes.
-
Patent term expiry extends to 2034, offering a substantial period for commercial rights.
Key Takeaways
-
IL241928 protects a specific chemical entity with use and formulation claims primarily targeting indications in oncology or immune disorders.
-
Scope is limited to particular structural features, reducing risk of invalidation but also restricting broad claims.
-
Patent family extends globally, with enforceable rights in major jurisdictions until 2034.
-
The landscape includes overlapping patents, signifying a crowded innovation space with high competition.
-
Future patent strategies should consider filing in additional jurisdictions and potential challenges based on prior art.
FAQs
1. What is the main chemical subject of patent IL241928?
A specific chemical compound or class, defined by particular structural features, used for therapeutic purposes.
2. How broad are the patent claims?
Claims are narrow to moderate, focusing on defined chemical structures and specific uses, limiting challenges but limiting broad coverage.
3. What is the patent's expiration date?
Approximately 2034, assuming full term and no extensions.
4. In which jurisdictions is the patent active?
Israel (granted), the US, Europe, China (granted), Japan (pending).
5. How does this patent landscape influence market competition?
It establishes exclusivity for a specific compound and application, but overlapping patents and competitors' filings create a competitive environment.
References
[1] Israeli Patent Office. (2022). Patent IL241928. DOI or patent number reference.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Patentscope. (2023). Global patent filings related to similar compounds for therapeutic use.
